Home Tags Lung Disease
Lung Disease Related Content
Karen Moor and Marlies Wijsenbeek from the Erasmus Medical Center, Rotterdam explore the role of eHealth tools in idiopathic pulmonary fibrosis care and research.
Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
The restriction or inhalation of common sugar could one day treat a range of respiratory diseases, according to new research led by University of Manchester biologists.
The University of Manchester found that patients with common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems.
New figures show nearly 18 million patients are exposed to pollution, registered at GP surgeries with unsafe levels in the UK: read on to find out who is affected by these findings
Michael Roth, Research Group Leader at the University Hospital Basel explains what asthma is, its health impact and charts research landscape in the field.
Michael Roth, Research Group Leader at the University Hospital Basel & University Basel share his expertise on asthma and COPD, the most prevalent chronic inflammatory diseases of the lung globally
An innovative new surgery could provide a breakthrough in treating early-stage lung cancer, based on a review of some of the first patients to receive the treatment.
Prof Dr Michael Roth asks the question, Why do we fail to find disease specific indicators for chronic inflammatory lung diseases?
Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective
Associate Professor of Medicine, Anesthesiology and Critical Care at Université Clermont Auvergne, Matthieu Jabaudon assesses the RAGE pathway in at-risk critically ill patients and asks if this is a step towards better acute respiratory distress syndrome (ARDS) prediction
Cecilia Van Cauwenberghe, from TechVision Group, Frost & Sullivan provides a fascinating overview of acute respiratory distress syndrome, including refocusing clinical concerns and disease management, as well as the overall characteristics and health implications
Revolutionary discovery brings hope to lung disease sufferers after scientists from Université Paris-Saclay find a way to stop the deterioration of the arteries
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group highlights technology interventions that address dyspnoea – focussing on point-of-care lung ultrasonography The Murray and Nadel’s Textbook of Respiratory Medicine (Schwartzstein and Adams, 2016), etymologically defines dyspnoea from the Greek dys (painful, difficult) and pneuma (breath). Clinically, dyspnoea constitutes a medical...
Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...
Matthieu JABAUDON from Université Clermont Auvergne unveils his thoughts on distinct acute respiratory distress syndrome (ARDS) morphotypes based on lung imaging patterns It has long been recognised that acute respiratory distress syndrome (ARDS) is a clinical syndrome with marked heterogeneity in its presentation and clinical course (see www.openaccessgovernment.org/acute-respiratory-distress-syndrome-2/34971). One approach to...
CEO of Roy Castle Lung Cancer Foundation, Paula Chadwick, explains why it is now the time to finally prioritise lung health The events of Tuesday 21st November 2017 have the potential to change the lives of thousands of people in England. It was the day NHS England finally prioritised early...
Prof Dr Michael Roth (PhD) at University Hospital Basel looks at pneumology & pulmonary cell research, in this profile of the organisation's research
12Page 1 of 2